CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

EZH2 activating mutation

Gene: EZH2 · Type: mutation

Indications: Follicular lymphoma, Epithelioid sarcoma

SensitivityResistanceCIViC Context

Linked CIViC Profile: EZH2 MUTATION

Evidence Level Distribution

Level B: 2
LevelTypeDirectionSignificanceDiseaseDrugsRating
BPrognosticSupportsBetter OutcomeFollicular Lymphoma4
BPrognosticSupportsPoor OutcomeMyelodysplastic Syndrome3